Last $1.68 USD
Change Today -0.03 / -1.75%
Volume 6.0K
KDUS On Other Exchanges
Symbol
Exchange
OTC BB
As of 5:20 PM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

767 Fifth Avenue

New York, NY 10153

United States

Phone: 212-702-4300

Fax:

Cadus Corporation, through its subsidiary, Cadus Technologies, Inc., focuses on licensing yeast-based and other drug discovery technologies to third parties. The company holds all patents, patent applications, know how, licenses and drug discovery technologies. Traditional Drug Discovery Drug discovery consists of three key elements: the target, such as a receptor, on which the drug would act, the potential drug candidates, which include organic chemicals, proteins or peptides, and the assays or tests to screen these compounds to determine their effect on the target. Yeast The company has developed technologies based on yeast that are useful in identifying drug discovery candidates targeted at G Protein-coupled receptors. Yeast is a single–celled microorganism that is commonly used to make bread, beer, and wine. Hybrid Yeast Cells The company developed a proprietary technology to insert human genes into yeast cells to create hybrid yeast cells. Its scientists typically created hybrid yeast cells by replacing yeast G Protein–coupled receptor genes and certain signaling molecules with their human equivalents. These hybrid yeast cells express a human G Protein–coupled receptor and a portion of its signaling pathway. These hybrid yeast cells can be used to identify those compounds that act as agonists or antagonists to that receptor or a molecule that is in its signaling pathway. The company designed and developed approximately 25,000 genetically different yeast strains that can be used to build novel hybrid yeast cells. Patents As of March 15, 2013, the subsidiary is the assignee of 23 issued U.S. patents and 2 related granted foreign patents covering aspects of its yeast technology and is the exclusive worldwide licensee of 2 issued U.S. patents and 1 related granted foreign patent for use in drug discovery. History The company was founded in 1992. It was incorporated in 1992, under the laws of the state of Delaware. The company was formerly known as Cadus Pharmaceutical Corporation and changed its name to Cadus Corporation in 2003.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KDUS:US $1.68 USD -0.03

KDUS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KDUS.
View Industry Companies
 

Industry Analysis

KDUS

Industry Average

Valuation KDUS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 1.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CADUS CORP, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.